Extensive Cerebral Venous Sinus Thrombosis (CVST) After the First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine without Thrombotic Thrombocytopenia Syndrome (TTS) in a Healthy Woman

Ali Alhashim; Kawther Hadhiah; Zahra Al khalifah; Fatimah Mohammed Alhaddad; Sara A. Al ARhain; Faisal H. Bin Saif; Ahmad Abid; Omar Al Gamdi; Feras Alsulaiman; Mustafa AlQarni

doi:10.12659/AJCR.934744

09 February 2022 : Case report Saudi Arabia

Extensive Cerebral Venous Sinus Thrombosis (CVST) After the First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine without Thrombotic Thrombocytopenia Syndrome (TTS) in a Healthy Woman

Unusual clinical course, Adverse events of drug therapy, Educational Purpose (only if useful for a systematic review or synthesis)

Ali Alhashim

^1ABDEF*, Kawther Hadhiah^1EF, Zahra Al khalifah^1F, Fatimah Mohammed Alhaddad^1EF, Sara A. Al ARhain^1F, Faisal H. Bin Saif^1B, Ahmad Abid^1B, Omar Al Gamdi^1F, Feras Alsulaiman

^1BE, Mustafa AlQarni^1EF

DOI: 10.12659/AJCR.934744

Am J Case Rep 2022; 23:e934744

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

View HTML version

Figure 2. CT-venogram sagittal view (A) showing filling defect in the proximal segment of left internal jugular vein owing to thrombus extension. (B) normal filling of internal jugular vein on the right side.

Back to the Article

Extensive Cerebral Venous Sinus Thrombosis (CVST) After the First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine without Thrombotic Thrombocytopenia Syndrome (TTS) in a Healthy Woman

Your Privacy